UNSPSC 85522906: Revision of infusion device in upper vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in upper vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WY33Z

UNSPSC 85522906 Revision of infusion device in upper vein, percutaneous approach is a Commodity code with minimal recent state and local procurement activity aligned to its medical device scope. The source contains six recent state and local opportunities, but only one—Harris County Juvenile Probation Department's RFI for specialty and emergency medical services for detained youth—touches clinical care delivery broadly; the others address occupational medical surveillance, disability medical evaluations, surgical benefit carve-outs, pharmacy benefit management, temporary health professional staffing, and independent medical evaluations for pension determinations. None of these opportunities involve infusion devices or percutaneous vascular revision procedures. The code appears misaligned with actual state and local purchasing in the opportunities presented.

The recent activity originates from diverse issuing bodies: the City of Phoenix Retirement Office (pension-related medical evaluations, RFP, due October 16, 2026), the City of Long Beach (surgical procedure benefits, RFP, due October 7, 2026), the Washington State Department of Transportation (occupational medical surveillance, RFP, due October 9, 2026), Harris County Juvenile Probation Department (specialty medical services RFI, due September 25, 2026), Collier County Board of County Commissioners (pharmacy benefit management, RFP, April 9, 2026), and the County of Santa Clara Health System (temporary health professional staffing, RFP, due October 7, 2026). Geographic representation includes Arizona, California, Washington, Texas, and Florida. Because the code's nominal scope—infusion device revision procedures—appears unrelated to the current state and local opportunities tagged under it, the code shows no actionable market signal for vendors in that device category.